Kais Zakharia to Angiogenesis Inhibitors
This is a "connection" page, showing publications Kais Zakharia has written about Angiogenesis Inhibitors.
Connection Strength
0.027
-
Zakharia Y, Zakharia K, Rixe O. Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma. Expert Opin Drug Discov. 2015; 10(8):925-35.
Score: 0.027